CRH Medical Corp (TSE:CRH) – Analysts at Cormark dropped their Q3 2017 earnings per share (EPS) estimates for CRH Medical Corp in a report issued on Monday. Cormark analyst D. Novak now anticipates that the company will post earnings of $0.05 per share for the quarter, down from their previous forecast of $0.08. Cormark also issued estimates for CRH Medical Corp’s Q4 2018 earnings at $0.07 EPS.

Several other research analysts also recently weighed in on CRH. Scotiabank dropped their price target on CRH Medical Corp from C$6.75 to C$6.00 and set an “outperform” rating for the company in a research note on Monday. TD Securities dropped their price target on CRH Medical Corp from C$5.50 to C$4.00 and set a “hold” rating for the company in a research note on Monday. Beacon Securities downgraded CRH Medical Corp from a “buy” rating to a “hold” rating in a research note on Thursday, August 3rd. National Bank Financial dropped their price target on CRH Medical Corp from C$7.00 to C$5.25 and set an “outperform” rating for the company in a research note on Friday, August 4th. Finally, Royal Bank Of Canada dropped their price target on CRH Medical Corp from C$6.00 to C$5.00 and set an “outperform” rating for the company in a research note on Friday, August 4th. Three investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. CRH Medical Corp currently has an average rating of “Buy” and an average target price of C$5.06.

WARNING: “Q3 2017 EPS Estimates for CRH Medical Corp (CRH) Reduced by Cormark” was originally posted by American Banking News and is the property of of American Banking News. If you are reading this piece of content on another website, it was illegally copied and republished in violation of United States and international trademark & copyright law. The original version of this piece of content can be read at https://www.americanbankingnews.com/2017/09/26/q3-2017-eps-estimates-for-crh-medical-corp-crh-reduced-by-cormark.html.

Shares of CRH Medical Corp (TSE CRH) opened at 3.00 on Tuesday. CRH Medical Corp has a 52 week low of $2.63 and a 52 week high of $12.35. The stock has a market capitalization of $222.31 million and a P/E ratio of 30.61. The company has a 50-day moving average of $3.17 and a 200-day moving average of $7.16.

In other news, Director David Johnson sold 30,000 shares of the stock in a transaction that occurred on Wednesday, June 28th. The stock was sold at an average price of C$5.67, for a total transaction of C$170,100.00.

CRH Medical Corp Company Profile

CRH Medical Corporation is a Canada-based healthcare products and services company. The Company focused on providing physicians with services and products for the treatment of gastrointestinal diseases. The Company also provides anesthesiology services to gastroenterologists in the United States through its subsidiaries.

Earnings History and Estimates for CRH Medical Corp (TSE:CRH)

Receive News & Ratings for CRH Medical Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH Medical Corp and related companies with MarketBeat.com's FREE daily email newsletter.